Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Cosmecca Korea

KOSDAQ:A241710
Snowflake Description

Good value with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
A241710
KOSDAQ
₩81B
Market Cap
  1. Home
  2. KR
  3. Household
Company description

Cosmecca Korea Co., Ltd. engages in the research and development, manufacture, and sale of cosmetics. The last earnings update was 138 days ago. More info.


Add to Portfolio Compare Print
  • Cosmecca Korea has significant price volatility in the past 3 months.
A241710 Share Price and Events
7 Day Returns
20.6%
KOSDAQ:A241710
9.1%
KR Personal Products
16.4%
KR Market
1 Year Returns
-67.8%
KOSDAQ:A241710
-26.1%
KR Personal Products
-21%
KR Market
A241710 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Cosmecca Korea (A241710) 20.6% -26.8% -33.6% -67.8% -77.2% -
KR Personal Products 9.1% -7.7% -18.4% -26.1% -27.7% -34.9%
KR Market 16.4% -13.2% -21.2% -21% -20.9% -20.8%
1 Year Return vs Industry and Market
  • A241710 underperformed the Personal Products industry which returned -26.1% over the past year.
  • A241710 underperformed the Market in Korea (Republic of) which returned -21% over the past year.
Price Volatility
A241710
Industry
5yr Volatility vs Market

Value

 Is Cosmecca Korea undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Cosmecca Korea to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Cosmecca Korea.

KOSDAQ:A241710 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 4 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 10%
Perpetual Growth Rate 10-Year KR Government Bond Rate 3.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for KOSDAQ:A241710
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year KR Govt Bond Rate 3.4%
Equity Risk Premium S&P Global 6.1%
Personal Products Unlevered Beta Simply Wall St/ S&P Global 0.6
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.601 (1 + (1- 30%) (123.88%))
1.082
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.08
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 3.43% + (1.082 * 6.07%)
10%

Discounted Cash Flow Calculation for KOSDAQ:A241710 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Cosmecca Korea is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

KOSDAQ:A241710 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (KRW, Millions) Source Present Value
Discounted (@ 10%)
2020 -3,750.00 Analyst x2 -3,409.23
2021 6,150.00 Analyst x2 5,083.06
2022 11,109.86 Est @ 80.65% 8,348.03
2023 17,496.10 Est @ 57.48% 11,952.03
2024 24,716.18 Est @ 41.27% 15,349.95
2025 32,110.23 Est @ 29.92% 18,129.85
2026 39,164.86 Est @ 21.97% 20,103.54
2027 45,591.05 Est @ 16.41% 21,275.54
2028 51,296.60 Est @ 12.51% 21,762.80
2029 56,318.14 Est @ 9.79% 21,721.99
Present value of next 10 years cash flows ₩140,317.00
KOSDAQ:A241710 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= ₩56,318.14 × (1 + 3.43%) ÷ (10% – 3.43%)
₩887,213.04
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ₩887,213.04 ÷ (1 + 10%)10
₩342,199.40
KOSDAQ:A241710 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ₩140,317.00 + ₩342,199.40
₩482,516.40
Equity Value per Share
(KRW)
= Total value / Shares Outstanding
= ₩482,516.40 / 10.68
₩45179.44
KOSDAQ:A241710 Discount to Share Price
Calculation Result
Value per share (KRW) From above. ₩45,179.44
Current discount Discount to share price of ₩7,540.00
= -1 x (₩7,540.00 - ₩45,179.44) / ₩45,179.44
83.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Cosmecca Korea is available for.
Intrinsic value
>50%
Share price is ₩7540 vs Future cash flow value of ₩45179.44
Current Discount Checks
For Cosmecca Korea to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Cosmecca Korea's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Cosmecca Korea's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Cosmecca Korea's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Cosmecca Korea's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
KOSDAQ:A241710 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in KRW ₩254.34
KOSDAQ:A241710 Share Price ** KOSDAQ (2020-03-31) in KRW ₩7540
Korea (Republic of) Personal Products Industry PE Ratio Median Figure of 23 Publicly-Listed Personal Products Companies 23.69x
Korea (Republic of) Market PE Ratio Median Figure of 1,291 Publicly-Listed Companies 11.51x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Cosmecca Korea.

KOSDAQ:A241710 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= KOSDAQ:A241710 Share Price ÷ EPS (both in KRW)

= 7540 ÷ 254.34

29.65x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cosmecca Korea is overvalued based on earnings compared to the KR Personal Products industry average.
  • Cosmecca Korea is overvalued based on earnings compared to the Korea (Republic of) market.
Price based on expected Growth
Does Cosmecca Korea's expected growth come at a high price?
Raw Data
KOSDAQ:A241710 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 29.65x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
38.4%per year
Korea (Republic of) Personal Products Industry PEG Ratio Median Figure of 12 Publicly-Listed Personal Products Companies 0.9x
Korea (Republic of) Market PEG Ratio Median Figure of 355 Publicly-Listed Companies 0.64x

*Line of best fit is calculated by linear regression .

KOSDAQ:A241710 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 29.65x ÷ 38.4%

0.77x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cosmecca Korea is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Cosmecca Korea's assets?
Raw Data
KOSDAQ:A241710 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in KRW ₩12,150.77
KOSDAQ:A241710 Share Price * KOSDAQ (2020-03-31) in KRW ₩7540
Korea (Republic of) Personal Products Industry PB Ratio Median Figure of 38 Publicly-Listed Personal Products Companies 1.4x
Korea (Republic of) Market PB Ratio Median Figure of 1,928 Publicly-Listed Companies 0.76x
KOSDAQ:A241710 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= KOSDAQ:A241710 Share Price ÷ Book Value per Share (both in KRW)

= 7540 ÷ 12,150.77

0.62x

* Primary Listing of Cosmecca Korea.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cosmecca Korea is good value based on assets compared to the KR Personal Products industry average.
X
Value checks
We assess Cosmecca Korea's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Personal Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Personal Products industry average (and greater than 0)? (1 check)
  5. Cosmecca Korea has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Cosmecca Korea expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
38.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Cosmecca Korea expected to grow at an attractive rate?
  • Cosmecca Korea's earnings growth is expected to exceed the low risk savings rate of 3.4%.
Growth vs Market Checks
  • Cosmecca Korea's earnings growth is expected to exceed the Korea (Republic of) market average.
  • Cosmecca Korea's revenue growth is expected to exceed the Korea (Republic of) market average.
Annual Growth Rates Comparison
Raw Data
KOSDAQ:A241710 Future Growth Rates Data Sources
Data Point Source Value (per year)
KOSDAQ:A241710 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts 38.4%
KOSDAQ:A241710 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 4 Analysts 13.9%
Korea (Republic of) Personal Products Industry Earnings Growth Rate Market Cap Weighted Average 18.7%
Korea (Republic of) Personal Products Industry Revenue Growth Rate Market Cap Weighted Average 7.5%
Korea (Republic of) Market Earnings Growth Rate Market Cap Weighted Average 28.5%
Korea (Republic of) Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
KOSDAQ:A241710 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in KRW Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
KOSDAQ:A241710 Future Estimates Data
Date (Data in KRW Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 456,933 20,233 12,400 3
2020-12-31 413,600 18,400 11,200 4
2020-03-31
2019-12-31 347,700 17,567 7,500 2
KOSDAQ:A241710 Past Financials Data
Date (Data in KRW Millions) Revenue Cash Flow Net Income *
2019-09-30 338,290 24,402 2,715
2019-06-30 355,203 8,414 4,106
2019-03-31 335,242 17,598 8,090
2018-12-31 303,293 10,837 8,972
2018-09-30 272,601 6,496 12,943
2018-06-30 214,660 16,409 11,601
2018-03-31 184,919 5,796 8,488
2017-12-31 182,328 10,441 9,934
2017-09-30 182,438 11,074 11,919
2017-06-30 187,953 2,568 13,176
2017-03-31 181,618 6,973 12,240
2016-12-31 165,176 4,401 11,505

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Cosmecca Korea's earnings are expected to grow significantly at over 20% yearly.
  • Cosmecca Korea's revenue is expected to grow by 13.9% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
KOSDAQ:A241710 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from Cosmecca Korea Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

KOSDAQ:A241710 Future Estimates Data
Date (Data in KRW Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 1,161.67 1,259.00 1,004.00 3.00
2020-12-31 896.67 1,071.00 604.00 3.00
2020-03-31
2019-12-31 704.50 771.00 638.00 2.00
KOSDAQ:A241710 Past Financials Data
Date (Data in KRW Millions) EPS *
2019-09-30 254.34
2019-06-30 384.63
2019-03-31 757.28
2018-12-31 840.10
2018-09-30 880.98
2018-06-30 868.82
2018-03-31 795.22
2017-12-31 930.00
2017-09-30 1,833.47
2017-06-30 1,837.61
2017-03-31 1,334.64
2016-12-31 1,354.00

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Cosmecca Korea is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Cosmecca Korea's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Korea (Republic of) market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Korea (Republic of) market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Cosmecca Korea has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Cosmecca Korea performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Cosmecca Korea's growth in the last year to its industry (Personal Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Cosmecca Korea's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
  • Cosmecca Korea's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Cosmecca Korea's 1-year earnings growth is negative, it can't be compared to the KR Personal Products industry average.
Earnings and Revenue History
Cosmecca Korea's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Cosmecca Korea Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

KOSDAQ:A241710 Past Revenue, Cash Flow and Net Income Data
Date (Data in KRW Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 338,289.77 2,715.49 35,617.03 9,428.93
2019-06-30 355,202.82 4,105.93 35,410.10 9,113.00
2019-03-31 335,242.14 8,090.13 31,131.50 8,624.47
2018-12-31 303,292.62 8,972.24 29,385.99 8,188.56
2018-09-30 272,601.20 12,942.80 26,508.13 7,933.10
2018-06-30 214,660.44 11,601.15 22,493.76 7,249.18
2018-03-31 184,918.99 8,488.00 22,362.57 6,955.55
2017-12-31 182,327.85 9,934.09 20,080.08 6,518.72
2017-09-30 182,437.56 11,918.63 18,699.61 5,817.93
2017-06-30 187,953.13 13,175.63 17,621.33 5,718.11
2017-03-31 181,618.27 12,240.05 16,823.87 5,601.59
2016-12-31 165,176.12 11,504.55 15,748.57 5,420.05
2016-09-30 147,204.43 9,708.11 14,620.48 5,380.04
2016-06-30 131,028.38 8,864.99 13,438.80 5,260.11
2016-03-31 110,391.11 6,346.79 11,250.25 4,678.68
2015-12-31 99,149.81 5,027.18 10,357.76 4,161.19
2014-12-31 68,318.42 1,355.24 8,042.77 3,162.87

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Cosmecca Korea has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Cosmecca Korea used its assets less efficiently than the KR Personal Products industry average last year based on Return on Assets.
  • Cosmecca Korea's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Cosmecca Korea's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Personal Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Cosmecca Korea has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Cosmecca Korea's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Cosmecca Korea's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Cosmecca Korea is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Cosmecca Korea's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Cosmecca Korea's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Cosmecca Korea Company Filings, last reported 6 months ago.

KOSDAQ:A241710 Past Debt and Equity Data
Date (Data in KRW Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 175,800.10 95,027.55 17,213.98
2019-06-30 173,076.60 96,629.95 12,499.98
2019-03-31 172,510.10 85,727.35 13,696.00
2018-12-31 171,616.12 79,967.31 13,310.67
2018-09-30 168,559.07 70,019.80 10,573.40
2018-06-30 165,661.34 66,891.68 29,770.64
2018-03-31 115,074.80 2,233.93 29,015.76
2017-12-31 113,468.53 2,138.64 38,190.21
2017-09-30 112,996.32 2,287.74 44,794.19
2017-06-30 112,040.39 2,273.35 41,684.30
2017-03-31 106,981.39 2,227.91 49,024.54
2016-12-31 104,839.06 2,399.85 50,441.90
2016-09-30
2016-06-30 29,202.03 16,127.49 3,615.95
2016-03-31 22,865.23 18,094.88 5,669.54
2015-12-31 22,865.23 18,094.88 5,669.54
2014-12-31 18,031.87 17,262.12 4,097.49
  • Cosmecca Korea's level of debt (54.1%) compared to net worth is high (greater than 40%).
  • Unable to establish if Cosmecca Korea's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (25.7%, greater than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 0.8x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Cosmecca Korea's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Cosmecca Korea has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Cosmecca Korea's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.33%
Current annual income from Cosmecca Korea dividends. Estimated to be 1.33% next year.
If you bought ₩2,000 of Cosmecca Korea shares you are expected to receive ₩27 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Cosmecca Korea's pays a lower dividend yield than the bottom 25% of dividend payers in Korea (Republic of) (1.34%).
  • Cosmecca Korea's dividend is below the markets top 25% of dividend payers in Korea (Republic of) (4.08%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
KOSDAQ:A241710 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
Korea (Republic of) Personal Products Industry Average Dividend Yield Market Cap Weighted Average of 18 Stocks 0.8%
Korea (Republic of) Market Average Dividend Yield Market Cap Weighted Average of 904 Stocks 3%
Korea (Republic of) Minimum Threshold Dividend Yield 10th Percentile 0.7%
Korea (Republic of) Bottom 25% Dividend Yield 25th Percentile 1.3%
Korea (Republic of) Top 25% Dividend Yield 75th Percentile 4.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

KOSDAQ:A241710 Future Dividends Estimate Data
Date (Data in ₩) Dividend per Share (annual) Avg. No. Analysts
2021-12-31 100.00 3.00
2020-12-31 100.00 3.00
2020-03-31
2019-12-31 100.00 4.00
KOSDAQ:A241710 Past Annualized Dividends Data
Date (Data in ₩) Dividend per share (annual) Avg. Yield (%)
2019-11-14 100.000 0.950

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • It is too early to tell whether Cosmecca Korea has stable dividend payments.
  • Cosmecca Korea only just started paying a dividend, it is too early to tell if payments are increasing.
Current Payout to shareholders
What portion of Cosmecca Korea's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (2.5x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be thoroughly covered by earnings (10.9x coverage).
X
Income/ dividend checks
We assess Cosmecca Korea's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.7%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Cosmecca Korea afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Cosmecca Korea has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Cosmecca Korea's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Im-Rae Cho
AGE 66
CEO Bio

Mr. Im-Rae Cho serves as Chief Executive Officer and Director at Cosmecca Korea Co., Ltd. Mr. Cho studied at Sungkyunkwan University with Majored in Chemistry Department.

CEO Compensation
  • Insufficient data for Im-Rae to compare compensation growth.
  • Insufficient data for Im-Rae to establish whether their remuneration is reasonable compared to companies of similar size in .
Management Team

Im-Rae Cho

TITLE
CEO & Director
AGE
66

Jae-Sung Ji

TITLE
President and GM of Korean Corporation Production
AGE
63

Sun-Ki Park

TITLE
Senior MD
AGE
54

Sun-Jong Bu

TITLE
MD & General Director of Chinese Corporate Sales
AGE
53

In-Sung Kim

TITLE
MD & General Director of Korean Corporate Factory
AGE
57

Young-Ha Lee

TITLE
MD & General Director of Basic Research Institute
AGE
59

Seung-Wook Yoo

TITLE
MD & General Director of Overseas Business
AGE
53

Jun-Cheol Cho

TITLE
MD & General Director of Overseas Business
AGE
53

Gi-Hyun Kim

TITLE
MD & General Director of Management Planning
AGE
55

Chang-Won Lee

TITLE
General Director of Management Support & Director
AGE
50
Board of Directors

Im-Rae Cho

TITLE
CEO & Director
AGE
66

Sun-Ki Park

TITLE
Senior MD
AGE
54

Chang-Won Lee

TITLE
General Director of Management Support & Director
AGE
50
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₩) Value (₩)
X
Management checks
We assess Cosmecca Korea's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Cosmecca Korea has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Cosmecca Korea Co., Ltd. engages in the research and development, manufacture, and sale of cosmetics. The company was founded in 1999 and is headquartered in Eumseong County, South Korea.

Details
Name: Cosmecca Korea Co., Ltd.
A241710
Exchange: KOSDAQ
Founded: 1999
₩80,527,200,000
10,680,000
Website: http://www.cosmecca.com
Address: Cosmecca Korea Co., Ltd.
17-9, 17-12 Daegeum-ro,
196 beon-gil,
Eumseong,
Chungcheongbuk-do, South Korea
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
KOSDAQ A241710 Share Capital KOSDAQ KR KRW 28. Oct 2016
Number of employees
Current staff
Staff numbers
0
Cosmecca Korea employees.
Industry
Personal Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/31 18:52
End of day share price update: 2020/03/31 00:00
Last estimates confirmation: 2020/03/13
Last earnings filing: 2019/11/14
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.